Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Cash from Operations (2021 - 2025)

Historic Cash from Operations for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to -$1.4 million.

  • Cardio Diagnostics Holdings' Cash from Operations fell 2039.64% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.8 million, marking a year-over-year decrease of 890.56%. This contributed to the annual value of -$5.0 million for FY2024, which is 1197.2% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Cash from Operations is -$1.4 million, which was down 2039.64% from -$1.6 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Cash from Operations' 5-year high stood at -$174.0 during Q3 2021, with a 5-year trough of -$3.1 million in Q4 2022.
  • In the last 5 years, Cardio Diagnostics Holdings' Cash from Operations had a median value of -$1.3 million in 2023 and averaged -$1.2 million.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Cash from Operations tumbled by 79865919.54% in 2022 and then skyrocketed by 4597.65% in 2023.
  • Over the past 5 years, Cardio Diagnostics Holdings' Cash from Operations (Quarter) stood at -$300944.0 in 2021, then crashed by 936.83% to -$3.1 million in 2022, then surged by 45.98% to -$1.7 million in 2023, then grew by 17.4% to -$1.4 million in 2024, then decreased by 0.08% to -$1.4 million in 2025.
  • Its Cash from Operations was -$1.4 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$1.4 million in Q1 2025.